Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed

BIOLOGICAL4 trials

Sponsors

Jennifer Woyach, National Cancer Institute (NCI), Mayo Clinic

Conditions

Advanced Fallopian Tube CarcinomaAdvanced Fallopian Tube High Grade Serous AdenocarcinomaAdvanced Ovarian CarcinomaAdvanced Ovarian CarcinosarcomaAdvanced Ovarian Clear Cell AdenocarcinomaAdvanced Ovarian Endometrioid AdenocarcinomaAdvanced Ovarian High Grade Serous AdenocarcinomaAdvanced Primary Peritoneal Carcinoma

Phase 2

Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Active, not recruitingNCT02518555

Jennifer WoyachChronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Start: 2016-01-12End: 2026-12-01Updated: 2026-01-07

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

RecruitingNCT06639074

Mayo ClinicAdvanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma, Advanced Ovarian Carcinoma +15

Start: 2024-11-08End: 2027-12-31Target: 78Updated: 2025-10-02

Phase 4

Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study

Active, not recruitingNCT03180034

National Cancer Institute (NCI)Human Papillomavirus Infection, Human Papillomavirus-Related Cervical Carcinoma

Start: 2017-11-29End: 2028-08-01Updated: 2025-09-04

Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial

Active, not recruitingNCT05237947

National Cancer Institute (NCI)Human Papillomavirus-Related Cervical Carcinoma

Start: 2022-03-01End: 2026-05-31Target: 5000Updated: 2026-04-03

Related Papers

Noninferiority of One HPV Vaccine Dose to Two Doses.

2025-12-031 citations

Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial

Vaccine2021-11-2937 citations

Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial.

2021-09-2737 citations

Immunogenicity and safety of the AS04-HPV-16/18 and HPV-6/11/16/18 human papillomavirus vaccines in asymptomatic young women living with HIV aged 15-25 years: A phase IV randomized comparative study.

2020-05-2510 citations

A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol.

2019-04-018 citations